Hi Welcome You can highlight texts in any article and it becomes audio news that you can hear
  • Sun. Nov 24th, 2024

New Drug Approved for Neuroblastoma Based Upon MSKCC Research

Byindianadmin

Nov 27, 2020

Naxitamab has actually been authorized for pediatric and adult patients with relapsed/refractory neuroblastoma in the bone and bone marrow that has reacted to prior therapy. FDA Approvals
Find Out More

Click to listen highlighted text!